NCT03832920

Brief Summary

Paravertebral Block (PVB) combined with general anesthesia (GA) is a conventional pain treatment for breast surgery but sometimes failures can occurs. The efficacy of this block has to be evaluated. Also, for the intra-operative analgesic evaluation of this block, it is necessary to measure intra-operative analgesia index. A monitor of nociception for patients under GA, the PhysiodolorisTM device, offers an index for measuring nociceptive inputs during surgery in anesthetized patients : the ANI index (based on the single R-R interval analysis). The purpose of this observational and prospective study is to assess the variations of this ANI index during breast surgery with or without axillary node dissection with a PVB. This will allow us to quantify the analgesic effect of a PVB during GA for unilateral radical breast surgery with or without axillary node dissection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

May 2, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2020

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

January 30, 2019

Last Update Submit

December 29, 2025

Conditions

Keywords

general anesthesiaparavertebral Blockanalgesia nociception index

Outcome Measures

Primary Outcomes (1)

  • Assessment of the ANI index

    Assessment of the area under the curve of the variation of the ANI index for the first minute of the surgical incision according to the PVB failure: incomplete or ineffective vs effective. The PVB failure will be evaluate with a cold test on the thoracic levels T2 and T6.

    first minute of the surgical incision

Secondary Outcomes (2)

  • Post Anesthesia Care Unit total dose of morphine will be compare according to the PVB failure or not groups.

    Just after surgery (day 0)

  • Evaluation of pain

    Just after surgery (day 0) and the day after surgery (day 1)

Interventions

A monitor of nociception for patients under general anesthesia

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women undergo for a breast surgery with or without axillary node dissection

You may qualify if:

  • American Society of Anesthesiologists score (ASA) I or II
  • Woman
  • Patients aged over 18 years
  • BMI between 17 and 30 kg/m2
  • Radical mastectomy with or without axillary node dissection.

You may not qualify if:

  • Preoperative consumption of opioid
  • Local Anesthesia allergy
  • Local skin inflammation at the puncture area
  • Inability to respond to pain assessment using a Numerical Rating Score (NRS)
  • Any contra-indication or patient's refusal for regional anesthesia B blocker medication
  • Pace maker
  • Inability to perform the PVB (at the appreciation of the anesthesiologist)
  • Change of surgical procedure other modified radical mastectomy with or without axillary node dissection.
  • Patient with a severe side effect or who cannot be controlled by additional therapy will be removed from the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Cancérologie de Lorraine (ICL)

Vandœuvre-lès-Nancy, France

Location

Related Publications (1)

  • Raft J, Lamotte AS, Schohn CH, Fritz C, Richebe P. Analgesia nociception index as a tool to assess the effectiveness of paravertebral block in total mastectomy: a prospective cohort study. Braz J Anesthesiol. 2026 Jan-Feb;76(1):844699. doi: 10.1016/j.bjane.2025.844699. Epub 2025 Nov 7.

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • RAFT JULIEN, MD

    Institut de Cancérologie de Lorraine (ICL)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
26 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2019

First Posted

February 6, 2019

Study Start

May 2, 2019

Primary Completion

June 26, 2020

Study Completion

March 1, 2023

Last Updated

January 2, 2026

Record last verified: 2025-12

Locations